InsidersTradesSigma
Follow the Phibro Animal Health Corporation stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €1.5bn. The latest transaction was reported on 16 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: BFI Co. LLC. The full history is openly available.
Analysts rate Phibro Animal Health Corporation Hold (neutral), based on 5 analysts. Average price target: US$45.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Phibro Animal Health Corporation es una empresa centrada en la salud animal, que ofrece productos y servicios para mejorar la salud y el bienestar del ganado. La empresa cotiza en el NASDAQ con el símbolo PAHC.